(ProPublica) – Critics say the current method of allowing manufacturers to choose the samples they send to labs is vulnerable to abuse and allows contaminated products to reach dispensaries. Colorado marijuana manufacturers would no longer be allowed to choose which … Read More
https://bioethics.com/archives/101515
